Literature DB >> 33408384

The effects of the COVID-19 pandemic on people with dementia.

Katya Numbers1, Henry Brodaty2,3.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33408384      PMCID: PMC7786184          DOI: 10.1038/s41582-020-00450-z

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
The COVID-19 pandemic has had a unique impact on people with Alzheimer disease (AD) and other dementias. As research into this impact has accumulated throughout 2020, a clear picture has emerged that this population is particularly susceptible not just to SARS-CoV-2 infection and its effects, but also to the negative effects of the measures taken worldwide to control the spread of the virus. Large-scale clinical data suggest that, even when old age and medical comorbidities such as hypertension and diabetes are taken into account, people with dementia are more likely to contract COVID-19 than people without dementia. Several reasons underlie the increased risk of SARS-CoV-2 infection in people with dementia, which are described in an important overview published in August[1]. First, cognitive impairment and neuropsychiatric symptoms make it challenging for individuals with dementia to understand and comply with safeguarding procedures, such as wearing masks and maintaining appropriate physical distancing[1]. Ignoring or forgetting warnings and an inability to follow self-quarantine measures increase the risk of infection. people with dementia are more likely to contract COVID-19 than people without dementia In addition, most people who live in institutional settings (nursing or care homes), where rates of infection are disproportionately high worldwide[2], have dementia. Such living arrangements facilitate rapid transmission of the virus as residents and staff congregate and live within close proximity. Physical distancing is not feasible for residents who are dependent on staff to assist with basic activities of daily living (for example, toileting, bathing and eating). Furthermore, dementia-associated neuropsychiatric symptoms, such as agitation, intrusiveness or wandering, can also undermine safety protocols and increase the risk of infection among staff and other residents[1]. Accordingly, nursing and care homes have implemented increasingly severe lockdown measures, which further exacerbate pre-existing neuropsychiatric symptoms among residents with dementia[3]. As well as being at increased risk of contracting COVID-19, older adults with dementia are also more likely to have more severe disease consequences than those without dementia[4-7]. A large community cohort study conducted in the UK has shown that the risk of serious COVID-19 (defined as a requirement for hospitalization) was threefold higher for individuals with a diagnosis of dementia than for those without dementia[4]. The risk factors for dementia — age, obesity, cardiovascular disease, hypertension and diabetes mellitus — are also risk factors for SARS-CoV-2 infection[6] and for severe COVID-19. However, some evidence suggests that more specific mechanistic aspects of dementia and pre-existing brain pathology can increase the risk of neurological complications from COVID-19 (ref.[8]). In particular, a study of the UK Biobank cohort showed that the risk of COVID-19-related hospitalization was more than twofold higher among individuals who were homozygous for APOE ε4 than among individuals with the most common APOE ε3/ε3 genotype[8]. One possible mechanistic explanation for this association is that increased blood–brain barrier permeability associated with APOE ε4 leads to more extensive CNS inflammation in response to SARS-CoV-2 infection — in line with this hypothesis, APOE ε4 is known to exacerbate microglia-mediated neuroinflammation and subsequent neurodegeneration[9]. In addition, APOE ε4 is associated with increased cytokine production in response to inflammatory stimuli, which could intensify the already aggressive inflammatory response associated with COVID-19, resulting in a so-called cytokine storm[10]. The cytokine storm has been directly associated with lung injury, multi-organ failure and severe COVID-19 outcomes, including death[10]. The restrictions that have been implemented in many countries to control the pandemic have also had important neuropsychiatric consequences for patients with dementia. In the population as a whole, forced social isolation has led to an increase in reported psychiatric symptoms (for example, stress, anxiety and depression) for all individuals; this relationship seems to be moderated by the loneliness associated with prolonged periods of lockdown[1,3,9]. In nursing and care homes, older adults are likely to experience additional distress owing to the absence of relatives who would normally visit them, as well as strict limitations on social activities and interactions with fellow residents. Data collected during the first half of 2020 show that such social isolation during the pandemic is associated with manifestation and/or exacerbation of neuropsychiatric symptoms even in cognitively healthy older adults[1,9]. Several studies — summarized in a review published in October[3] — have shown that, in older adults with dementia, psychiatric symptoms caused by social isolation are linked to more severe neuropsychiatric and behavioural disturbances[3]. Social isolation combined with confusion in care home residents with dementia might result in even greater agitation, boredom and loneliness than in residents without dementia, thereby leading to more severe neuropsychiatric symptoms. These neuropsychiatric symptoms seem to arise directly from social restrictions, as longer lockdown periods result in more severe neuropsychiatric symptoms[3]. Furthermore, some experts have suggested that behavioural complications that result from prolonged periods of lockdown in older adults with dementia could become chronic[3]. Some consequences of neuropsychiatric disturbances, such as increased aggression and agitation, can be particularly challenging for carers and care home staff to manage. longer lockdown periods result in more severe neuropsychiatric symptoms In summary, the evidence to date indicates that older adults with dementia have a high risk of contracting COVID-19 and, once infected, have a high risk of disease-related morbidity and mortality. This population is often the first to go into, and the last to come out of, strict and prolonged periods of isolation to prevent SARS-CoV-2 infection, yet is at extremely high risk of worsening neuropsychiatric symptoms and severe behavioural disturbance as a direct result. Therefore, during and after the pandemic, implementation of caregiver support and the presence of skilled nursing home staff are essential to maintain social interaction and to provide extra support to older adults with dementia.
  9 in total

1.  Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.

Authors:  Graziano Onder; Giovanni Rezza; Silvio Brusaferro
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

Review 2.  The COVID-19 Cytokine Storm; What We Know So Far.

Authors:  Dina Ragab; Haitham Salah Eldin; Mohamed Taeimah; Rasha Khattab; Ramy Salem
Journal:  Front Immunol       Date:  2020-06-16       Impact factor: 7.561

3.  APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort.

Authors:  Chia-Ling Kuo; Luke C Pilling; Janice L Atkins; Jane A H Masoli; João Delgado; George A Kuchel; David Melzer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-10-15       Impact factor: 6.053

4.  Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort.

Authors:  Janice L Atkins; Jane A H Masoli; Joao Delgado; Luke C Pilling; Chia-Ling Kuo; George A Kuchel; David Melzer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-10-15       Impact factor: 6.053

5.  Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias.

Authors:  Eric E Brown; Sanjeev Kumar; Tarek K Rajji; Bruce G Pollock; Benoit H Mulsant
Journal:  Am J Geriatr Psychiatry       Date:  2020-04-18       Impact factor: 4.105

6.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

7.  Factors associated with COVID-19-related death using OpenSAFELY.

Authors:  Elizabeth J Williamson; Alex J Walker; Krishnan Bhaskaran; Seb Bacon; Chris Bates; Caroline E Morton; Helen J Curtis; Amir Mehrkar; David Evans; Peter Inglesby; Jonathan Cockburn; Helen I McDonald; Brian MacKenna; Laurie Tomlinson; Ian J Douglas; Christopher T Rentsch; Rohini Mathur; Angel Y S Wong; Richard Grieve; David Harrison; Harriet Forbes; Anna Schultze; Richard Croker; John Parry; Frank Hester; Sam Harper; Rafael Perera; Stephen J W Evans; Liam Smeeth; Ben Goldacre
Journal:  Nature       Date:  2020-07-08       Impact factor: 49.962

Review 8.  The Impact of COVID-19 Infection and Enforced Prolonged Social Isolation on Neuropsychiatric Symptoms in Older Adults With and Without Dementia: A Review.

Authors:  Riccardo Manca; Matteo De Marco; Annalena Venneri
Journal:  Front Psychiatry       Date:  2020-10-22       Impact factor: 4.157

Review 9.  Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID-19 pandemic, now and in the future.

Authors:  Vincent C T Mok; Sarah Pendlebury; Adrian Wong; Suvarna Alladi; Lisa Au; Philip M Bath; Geert Jan Biessels; Christopher Chen; Charlotte Cordonnier; Martin Dichgans; Jacqueline Dominguez; Philip B Gorelick; SangYun Kim; Timothy Kwok; Steven M Greenberg; Jianping Jia; Rajesh Kalaria; Miia Kivipelto; Kandiah Naegandran; Linda C W Lam; Bonnie Yin Ka Lam; Allen T C Lee; Hugh S Markus; John O'Brien; Ming-Chyi Pai; Leonardo Pantoni; Perminder Sachdev; Ingmar Skoog; Eric E Smith; Velandai Srikanth; Guk-Hee Suh; Joanna Wardlaw; Ho Ko; Sandra E Black; Philip Scheltens
Journal:  Alzheimers Dement       Date:  2020-08-12       Impact factor: 16.655

  9 in total
  40 in total

1.  Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study.

Authors:  Silvia Cascini; Nera Agabiti; Claudia Marino; Anna Acampora; Maria Balducci; Enrico Calandrini; Marina Davoli; Anna Maria Bargagli
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

2.  The Kids Are Alright (?). Infants' Development and COVID-19 Pandemic: A Cross-Sectional Study.

Authors:  Eleonora Ferrari; Lucia Palandri; Laura Lucaccioni; Giovanna Talucci; Erica Passini; Viola Trevisani; Elena Righi
Journal:  Int J Public Health       Date:  2022-06-20       Impact factor: 5.100

3.  COVID-19 and community-based care services: Experiences of people living with dementia and their informal carers in Italy.

Authors:  Ilaria Chirico; Giovanni Ottoboni; Clarissa Giebel; Alessandro Pappadà; Marco Valente; Valentina Degli Esposti; Mark Gabbay; Rabih Chattat
Journal:  Health Soc Care Community       Date:  2022-02-20

4.  SARS-CoV-2 outbreak in a Canadian suburban tertiary hospital necessitating full facility closure: a descriptive observational study.

Authors:  Jamil N Kanji; Y L Elaine Chan; Lesia R Boychuk; Curtiss Boyington; Sebora Turay; Melissa Kobelsky; Carolyn Doroshuk; Philana Choo; Susan Jacka; Erin Roberts; Karen Leighton; Stephanie W Smith; Christopher Sikora; Robert Black
Journal:  CMAJ Open       Date:  2022-02-22

Review 5.  Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer's Disease Patients.

Authors:  Fernando Bartolomé; Luigi Rosa; Piera Valenti; Francisco Lopera; Jesús Hernández-Gallego; José Luis Cantero; Gorka Orive; Eva Carro
Journal:  Front Immunol       Date:  2022-04-25       Impact factor: 8.786

6.  Clinical outcomes of COVID-19 infection among patients with Alzheimer's disease or mild cognitive impairment.

Authors:  Ying Wang; Mingfei Li; Lewis E Kazis; Weiming Xia
Journal:  Alzheimers Dement       Date:  2022-04-04       Impact factor: 16.655

7.  COVID-19 Case Fatality and Alzheimer's Disease.

Authors:  Qiang Zhang; Jordan L Schultz; Georgina M Aldridge; Jacob E Simmering; Youngcho Kim; Amy C Ogilvie; Nandakumar S Narayanan
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.160

8.  Association of COVID-19 Pandemic and Rate of Cognitive Decline in Patients with Dementia and Mild Cognitive Impairment: A Cross-sectional Study.

Authors:  Ismail Ibrahim Ismail; Walaa A Kamel; Jasem Y Al-Hashel
Journal:  Gerontol Geriatr Med       Date:  2021-03-23

9.  'This Adds Another Perspective': Qualitative Descriptive Study Evaluating Simulation-Based Training for Health Care Assistants, to Enhance the Quality of Care in Nursing Homes.

Authors:  Catherine Aicken; Lisa Hodgson; Kay de Vries; Iain Wilkinson; Zena Aldridge; Kathleen Galvin
Journal:  Int J Environ Res Public Health       Date:  2021-04-10       Impact factor: 3.390

10.  The Impact of the COVID-19 Pandemic on the Cognition of People with Dementia.

Authors:  Giacomo Tondo; Barbara Sarasso; Paola Serra; Fabiana Tesser; Cristoforo Comi
Journal:  Int J Environ Res Public Health       Date:  2021-04-18       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.